Skip to main content
. Author manuscript; available in PMC: 2017 Apr 25.
Published in final edited form as: Mov Disord. 2012 Sep 13;27(11):1392–1397. doi: 10.1002/mds.25157

TABLE 4.

Estimated differences in continuous outcomes by quartiles of baseline mean striatal binding

Number of Subjects P Value for Trend Estimated Differences (95% CI)
Q1 Q2 Q3 Q4
MMSE 491 0.0067 −0.9 (−1.6, −0.3) −0.3 (−0.9, 0.3) −0.2 (−0.8, 0.4) 0
MoCA 489 <0.0001 −1.9 (−2.9, −1.0) −0.6 (−1.5, 0.3) −0.1 (−0.9, 0.8) 0
UPDRS motor 487 <0.0001 7.1 (4.1, 10.1) 2.1 (−0.8, 4.9) 1.7 (−1.1, 4.4) 0
UPDRS ADL 489 <0.0001 3.3 (1.7, 4.9) 1.3 (−0.2, 2.9) 0.3 (−1.2, 1.7) 0

Parameter estimates (95% CIs) from separate multiple regressions adjusted for age, gender, duration of disease, and PreCEPT study treatment, as well as for use of DAAs and/or L-dopa at most recent visit (or assessment). Arrow indicates direction of worsening. Mean values for quartiles are shown in Table 2. The highest quartile is the reference category.